Diabetes may worsen outcomes after esophageal cancer surgery, study finds

NCT ID NCT06333665

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 605 patients with esophageal cancer who had minimally invasive surgery to remove their esophagus. Researchers compared those with and without type 2 diabetes to see if diabetes affected short-term complications and long-term survival. The goal is to understand whether good diabetes control or metformin use might improve outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If it works, this could clarify whether managing diabetes before surgery improves long-term survival for esophageal cancer patients.

What could go wrong

This is an observational study, not a treatment trial, so it cannot prove cause and effect. Results may not apply to all patients or settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus esophageal squamous cell carcinoma Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Army Medical Center of the People's Liberation Army

    Chongqing, Chongqing Municipality, 400042, China